Last updated: 11/03/2018 11:33:57

Study to identify and characterize bacteria causing Acute Otitis Media in young children in Turkey

GSK study ID
111339
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Other
Other
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Identification and characterization of the bacteria causing Acute Otitis Media (AOM) episodes in young children in Turkey
Trial description: The purpose of this study is to identify and characterize the bacteria causing complicated Acute Otitis Media episode in children >= 3 months to < 5 years in Turkey.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

Occurrence of bacterial pathogens isolated from middle ear fluid samples.

Timeframe: Not Applicable.

Secondary outcomes:

Occurrence of bacterial serotypes.

Timeframe: Not Applicable.

Antimicrobial susceptibility of bacteria isolated from middle ear fluid samples collected from sub-groups of complicated acute otitis media cases.

Timeframe: Not Applicable.

Occurrence of treatment failure of acute otitis media and of recurrent acute otitis media.

Timeframe: Not Applicable.

Occurrence of bacteria in acute otitis media cases vaccinated with a pneumococcal vaccine.

Timeframe: Not Applicable.

Occurrence of spontaneous otorrhoea.

Timeframe: Not Applicable.

Interventions:
  • Procedure/surgery: Tympanocenthesis and urine collection
  • Enrollment:
    0
    Primary completion date:
    Not applicable
    Observational study model:
    Case-Only
    Time perspective:
    Prospective
    Clinical publications:
    Not applicable
    Medical condition
    Infections, Streptococcal
    Product
    GSK2647154A
    Collaborators
    Not applicable
    Study date(s)
    November 2012 to February 2014
    Type
    Observational
    Phase
    Not applicable

    Participation criteria

    Sex
    Female & Male
    Age
    3 months - 5 years
    Accepts healthy volunteers
    No
    • Age: >= 3 months and < 5 years at the time they are seen by the paediatrician. The subject becomes ineligible on the fifth birthday.
    • Signs, symptoms, and conditions:
    • Hospitalised during the diagnosis of acute otitis media or during treatment.
    • Otitis externa, or otitis media with effusion.

    Trial location(s)

    Location
    Status
    Contact us
    Contact us
    Location
    GSK Investigational Site
    Istanbul, Turkey
    Status
    Will Be Recruiting
    Location
    GSK Investigational Site
    Izmir, Turkey
    Status
    Will Be Recruiting
    Location
    GSK Investigational Site
    Adana, Turkey
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Ankara, Turkey
    Status
    Will Be Recruiting
    Location
    GSK Investigational Site
    Izmir, Turkey, 35100
    Status
    Will Be Recruiting

    Study documents

    No study documents available.

    Results overview

    No study documents available

    Recruitment status
    Other
    Actual primary completion date
    Not applicable
    Actual study completion date
    Not applicable

    Plain language summaries

    Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

    Additional information about the trial

    Not applicable
    Participate in clinical trial
    Access to clinical trial data by researchers
    Visit website